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Background
Minimally invasive aortic valve replacement (MIAVR)
was first described in 1996 as an alternative to median
sternotomy for AVR. Its uptake has been sporadic in
cardiac surgery units in the UK. It remains unclear and
somewhat controversial whether it has superior patient
outcomes over conventional sternotomy. This survey
aims to explore the reason for the low uptake by consul-
tant surgeons in the UK and assess current opinions
regarding the benefits, evidence base and barriers to
MIAVR.
Methods
An online survey was created with 20 questions
designed to explore the reasons that the current consul-
tant population uses to base its practise on MIAVR. The
link was distributed by the UK Society of Cardiothoracic
Surgeons to the consultant members. Opinions on bene-
fits of MIAVR compared with conventional sternotomy
were evaluated along with potential barriers and areas
for future research. Information regarding use of
MIAVR in their clinical practice was obtained.
Results
Forty-nine consultants responded (response rate
approximately 30%).67% of the consultants have per-
formed MIAVR. 84% of the consultants identified that
MIAVR was performed in their unit. 45% who identified
themselves as performing MIAVR have carried out less
than 15 procedures. 22% have carried out more than 26
procedures.
Only 48% of consultants felt there was an overall benefit
of MIAVR when compared with conventional. Consultants
with less than 10 years experience had a significantly more
positive opinion of MIAVR than their more experienced
colleagues.
Conclusions
These results suggest that consultants’ opinions on the
benefits and drawbacks of MIAVR remain divided. It
has highlighted some perceived barriers and the desire
for further evidence on which to base practice. Cost-
benefit analysis would enable units to make an informed
decision on the most effective approach to patients
requiring AVR.
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